Transcriptomics

Dataset Information

0

TREM2 inhibition triggers anti-tumor cell activity of myeloid cells in glioblastoma [RNAseq]


ABSTRACT: The prevailing view is that myeloid cells in the tumor microenvironment (TME) are immunosuppressive and promote glioblastoma (GBM) progression. However, myeloid cells have the functional plasticity to restrict or support tumor cell growth. TREM2 plays important roles in brain microglial function in neurodegenerative diseases, but the role of TREM2 in the GBM TME has not been examined. We found TREM2 is highly expressed in myeloid subsets, including macrophages and microglia in human and mouse GBM tumors and that high TREM2 expression correlates with poor prognosis in GBM patients. TREM2 loss of function in human macrophages and mouse myeloid cells increased tumoricidal capacity. TREM2 in myeloid cells restricts IFNγ-induced immunoactivation and proinflammatory polarization. In orthotopic mouse GBM models, Trem2-/- mice and mice with acute brain Trem2 reduction demonstrate survival benefit. Trem2 inhibition reprograms myeloid phenotypes and increases PD-1+CD8+ T cells in the TME. Trem2 deficiency enhances the effectiveness of anti-PD-1 treatment and may represent a therapeutic strategy for GBM patients.

ORGANISM(S): Mus musculus

PROVIDER: GSE226172 | GEO | 2023/05/12

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-05-12 | GSE226292 | GEO
2020-08-13 | GSE151710 | GEO
2023-12-21 | GSE232040 | GEO
2023-06-29 | GSE235676 | GEO
2023-06-29 | GSE235672 | GEO
2023-06-29 | GSE235911 | GEO
2024-05-17 | GSE262811 | GEO
2021-10-24 | GSE176085 | GEO
2024-06-01 | GSE266884 | GEO
2022-12-31 | GSE203260 | GEO